Aurobindo Shares Soar 4% as USFDA Classifies Facility as VAI
Shares of Aurobindo Pharma Ltd soared roughly 4% on Wednesday, 6 May, after the company said that the US Food and Drug Administration (USFDA) has...
Tag : US Food & Drug Administration (USFDA)
Biocon Shares Slump 2% as USFDA Issues 5 Observations
Shares of Biocon Ltd fell 2% during the early trading hours on Thursday, 30 April, after the company announced that the US drug regulator had...
Aurobindo Pharma Hits 52-Week High on Twin USFDA Approvals
Shares of Aurobindo Pharma Limited touched a 52-week high of Rs 1,396.60 on the BSE on 20 April, rising 0.79% from the previous close of...
Glenmark Pharma Shares Slump 1% Despite USFDA Approval
Shares of Glenmark Pharmaceuticals Ltd were trading in the red and 1% lower on Thursday, 9 April, despite the company receiving final approval from the...
Marksans Pharma Shares Skyrocket 9% on USFDA Approval
Shares of Marksans Pharma Ltd skyrocketed 9% on 1 April after the firm announced that its Benzonatate Capsules had received approval from the US Food...
Aurobindo Pharma Shares Soar 3% as Arm Secures VAI from USFDA
Shares of Aurobindo Pharma Ltd soared 3% on 20 March after the company announced that its wholly owned subsidiary, Apitoria Pharma Pvt Ltd, has acquired...
Aurobindo Pharma Shares Trade Lower as Arm Secures 11 Observations
Shares of Aurobindo Pharma Ltd were trading in the red and 1% lower on 9 February after the US Food and Drug Administration (USFDA) inspected...
Indoco Remedies Shares Soar 7% on Securing USFDA Final Approval
Shares of Indoco Remedies Limited soared 7% on 30 January after the company announced securing final approval from the USFDA. In its regulatory filing, the...
Gland Pharma Shares Surge 4% on USFDA Approval
Shares of Gland Pharma Ltd surged 4% on 8 January after the company announced securing approval from the US Food and Drug Administration for its...
Cipla Shares Slump 4% as USFDA Gives Observations to Pharmathen International
Shares of Cipla Ltd slumped 5% on 7 January after the US Food and Drug Administration (USFDA) disclosed details of its findings on Pharmathen International....